Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Eosinophil cationic protein stimulates and major basic protein inhibits airway mucus secretion

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Screening for Wiskott-Aldrich syndrome by flow cytometry

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

Vis graf over relationer
Possible roles of eosinophil (EO) products in modulating the release of mucus from airway explants were investigated. Cell- and membrane-free lysates from purified human EOs (1 to 20 x 10(5)) caused a dose-dependent release of respiratory glycoconjugates (RGC) from cultured feline tracheal explants. Crude extracts from isolated EO granules also stimulated RGC release, suggesting that a granular protein might be responsible. Three proteins derived from EO granules, EO-derived neurotoxin, EO cationic protein (ECP), and major basic protein (MBP) were separated by sequential sizing and affinity chromatography. ECP (0.025 to 25 micrograms/ml) caused a dose-dependent increase in RGC release from both feline and human airway explants and also stimulated the release of the serous cell-marker, lactoferrin, from human bronchial explants. EO-derived neurotoxin (0.025 to 50 micrograms/ml) failed to affect RGC release, whereas MBP (50 micrograms/ml) significantly inhibited RGC release from feline explants. Thus, ECP stimulates RGC and lactoferrin release from airway explants, whereas MBP inhibits RGC release.
OriginalsprogEngelsk
TidsskriftJournal of Allergy and Clinical Immunology
Vol/bind87
Udgave nummer3
Sider (fra-til)689-98
Antal sider10
ISSN0091-6749
StatusUdgivet - mar. 1991

ID: 39874280